INVESTORS & MEDIA
Corporate Governance
| Date | Name | Title | Filing | Type | Shares Traded | Price | Total Held |
|---|---|---|---|---|---|---|---|
| May 20, 2013 |
SVP Finance and Admin CFO and
Trans History: 645
|
SVP Finance and Admin CFO and | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $16.80 | 135,803 |
| Nov 21, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $16.80 | 29,372 |
| Nov 21, 2012 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 16,923 |
| Feb 21, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $20.32 | 58,337 |
| Feb 21, 2012 |
SVP Clinical Development & Reg
Trans History: 208
|
SVP Clinical Development & Reg | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | -- |
| Oct 10, 2011 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | $21.34 | 20,000 |
| Oct 10, 2011 |
SVP Commercial
Trans History: 172
|
SVP Commercial | Form 4 | Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | 20,000 | -- | 18,128 |
| Jun 03, 2011 |
Director
Trans History: 368
|
Director | Form 4 | Bona fide gift | 20,000 | -- | 20,000 |
| Jun 03, 2011 |
Director
Trans History: 368
|
Director | Form 4 | Bona fide gift | 20,000 | -- | 20,000 |
| Apr 29, 2011 |
Director
Trans History: 312
|
Director | Form 4 | Conversion of derivative security | 20,000 | -- | 31,875 |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.